Desktop Health® Validates Flexcera® Smile Ultra+ Resin for All-on-X Implant Provisionals

Desktop Health, a leading brand in production-grade medical 3D printing from Desktop Metal, Inc. (NYSE: DM), has validated its Flexcera® Smile Ultra+ resin for use in dental implantology, specifically for All-on-X implant provisionals. Flexcera Smile Ultra+ is already FDA (510)k…

Read MoreDesktop Health® Validates Flexcera® Smile Ultra+ Resin for All-on-X Implant Provisionals

Eisai Chooses Medidata’s Clinical Data Studio to Boost Trial Efficiency and Patient Experience

Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions, has announced that Eisai Incorporated, the U.S. subsidiary of Tokyo-based Eisai Co., Ltd., is among the first to implement the new Medidata Clinical Data Studio. This advanced…

Read MoreEisai Chooses Medidata’s Clinical Data Studio to Boost Trial Efficiency and Patient Experience

Cardio Diagnostics Unveils CDIO.AI: New Website Showcases AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a frontrunner in AI-driven cardiovascular medicine, has unveiled its newly redesigned website, CDIO.AI. This upgraded platform underscores the Company’s commitment to an AI-first approach and showcases its advanced, scalable solutions for preventing, detecting, and…

Read MoreCardio Diagnostics Unveils CDIO.AI: New Website Showcases AI-Driven Cardiovascular Solutions

NovaBay Pharmaceuticals Closes $3.87M Public Offering with Partial Overallotment Exercise

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has announced the successful closing of its underwritten public offering, which included common stock, pre-funded warrants, and Series F-1, F-2, and F-3 warrants, raising approximately $3.87 million before underwriting discounts and expenses. This total…

Read MoreNovaBay Pharmaceuticals Closes $3.87M Public Offering with Partial Overallotment Exercise

Battelle to Help Medical Device Companies Navigate New ‘Forever Chemicals’ Regulations

Battelle, renowned for its extensive expertise in research, laboratory analysis, and consulting on Per- and Polyfluoroalkyl Substances (PFAS), is now leveraging its skills in response to the growing awareness and regulation of these chemicals. With increasing federal regulations like the…

Read MoreBattelle to Help Medical Device Companies Navigate New ‘Forever Chemicals’ Regulations